Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather H Cheng

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
The Canadian Journal of Urology|October 21, 2019
Current recommendations for prostate cancer genetic testing: NCCN prostate guidelineJames L Mohler, Celestia S Higano, Edward M Schaeffer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 16, 2016
Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and HarmsRoman Gulati, Heather H Cheng, Paul H Lange, et al.
European Urology|January 3, 2016
Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate CancerHeather H Cheng, Colin C Pritchard, Thomas Boyd, et al.
Clinical Genitourinary Cancer|July 13, 2017
Prostate Cancer Screening in a New Era of GeneticsHeather H Cheng, Colin C Pritchard, Bruce Montgomery, et al.
JCO Precision Oncology|September 11, 2020
Polyclonal <i>BRCA2</i> Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate CancerHeather H Cheng, Stephen J Salipante, Peter S Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear BenefitsRavi A Madan, Fatima Karzai, David J VanderWeele, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2021
Disparities in germline testing among racial minorities with prostate cancerNicole Weise, Justin Shaya, Juan Javier-Desloges, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Germline and Somatic Mutations in Prostate Cancer for the ClinicianHeather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, et al.
Journal of Virology|January 28, 2006
Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variantsHeather H Cheng, Maria M Anderson, F Claire Hankenson, et al.
Urologic Oncology|October 22, 2019
Ethnic disparities among men with prostate cancer undergoing germline testingDaniel Hyuck-Min Kwon, Hala T Borno, Heather H Cheng, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
The Canadian Journal of Urology|October 21, 2019
Current recommendations for prostate cancer genetic testing: NCCN prostate guidelineJames L Mohler, Celestia S Higano, Edward M Schaeffer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 16, 2016
Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and HarmsRoman Gulati, Heather H Cheng, Paul H Lange, et al.
European Urology|January 3, 2016
Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate CancerHeather H Cheng, Colin C Pritchard, Thomas Boyd, et al.
Clinical Genitourinary Cancer|July 13, 2017
Prostate Cancer Screening in a New Era of GeneticsHeather H Cheng, Colin C Pritchard, Bruce Montgomery, et al.
JCO Precision Oncology|September 11, 2020
Polyclonal <i>BRCA2</i> Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate CancerHeather H Cheng, Stephen J Salipante, Peter S Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear BenefitsRavi A Madan, Fatima Karzai, David J VanderWeele, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2021
Disparities in germline testing among racial minorities with prostate cancerNicole Weise, Justin Shaya, Juan Javier-Desloges, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Germline and Somatic Mutations in Prostate Cancer for the ClinicianHeather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, et al.
Journal of Virology|January 28, 2006
Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variantsHeather H Cheng, Maria M Anderson, F Claire Hankenson, et al.
Urologic Oncology|October 22, 2019
Ethnic disparities among men with prostate cancer undergoing germline testingDaniel Hyuck-Min Kwon, Hala T Borno, Heather H Cheng, et al.
Pageof 15